Full Name
George D. Yancopoulos, MD, PhD
Company
Regeneron Pharmaceuticals
Speaker Bio
George Damis Yancopoulos, M.D., Ph.D. is co-Founder, co-Chairman, President and Chief Scientific Officer of Regeneron. He is widely recognized as one of the most successful entrepreneurs, scientists and inventors in biotech history. George has been ranked among the top 10 most-cited scientists globally and is one of the most productive drug developers, responsible for two of the best-selling drugs in the world.

George built Regeneron – alongside long-time partner Leonard S. Schleifer, M.D., Ph.D. – into a premier biotech company, based on an unprecedented record of bringing important new medicines all the way from discovery to patients. He is principal inventor of Regeneron’s numerous approved medicines and industry-leading technologies, including VelocImmune®, the world’s first antibody producing mouse with a fully humanized immune system.

Under George’s leadership, Regeneron is routinely recognized as a “Top Employer” by Science magazine and among “America’s Best Companies” by Forbes. He has been honored as one of Forbes’ “America’s 100 Most Innovative Leaders” (alongside Jeff Bezos and Elon Musk), and Fortune’s “Pandemic’s Greatest Heroes” (alongside Anthony Fauci, M.D. and Bill Gates). He is an elected member of the National Academy of Sciences and graduated as valedictorian of Bronx High School of Science and Columbia University where he received his M.D. and Ph.D.
George D. Yancopoulos, MD, PhD